JULY ANNOUNCEMENTS
Twitter’s reach and ability to influence have made it a critical communication tool in all areas of life and work. Learn how UCSF cancer experts are harnessing the value of Twitter's bite-sized benefits. [read more]
Funded by various agencies across UCSF, the awards span a range of topics from health equity to therapy resistance to developing new screening methods.
Cancer Center leadership is calling on members to submit their boldest ideas for future research projects and collaborations that will drive funding priorities and scientific emphasis over the coming decade.
Job Opportunity
The Helen Diller Family Comprehensive Cancer Center is seeking a Program Manager for the newly launched Living Therapeutics Initiative. Please share this opportunity with your networks.
Welcome New Members
Jonathan Chou, MD, PhD - Associate Member, Prostate Cancer
Awards & Distinctions
Allan Balmain, PhD, FRS and team -- including UCSF co-investigators Kim Rhoads, MD, MS, MPH and Luke Gilbert, PhD -- were shortlisted for the 2021 Cancer Grand Challenges awards. Learn more.





Meng Wang, PhD received a Melanoma Research Alliance Dermatology Fellows Award for a project, "Characterizing the Genomic Evolution of Acral Lentiginous Melanoma."

Neil Shah, MD and team received a grant from the National Cancer Institute for a project, "Development of potent, selective, non-myelotoxic FLT3 inhibitors that retain efficacy against common mechanisms of resistance."

Eric Collisson, MD and team received a grant from the National Cancer Institute for a project, "Understanding efficacy and Fe(II)-promoted activation of 1,2,4-Trioxolanes in cancer."
In the News
Recent Publications
Kuzuoglu-Ozturk D, Hu Z, Rama M, Devericks E, Weiss J, Chiang GG, Worland ST, Brenner SE, Goodarzi H, Gilbert LA, Ruggero D. Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome. Cell Rep. 2021 Jun 29;35(13):109321.

Kelley RK, Greten TF. Hepatocellular Carcinoma - Origins and Outcomes. N Engl J Med. 2021 Jul 15;385(3):280-282.

Chen WC, To MD, Westcott PMK, Delrosario R, Kim IJ, Philips M, Tran Q, Bollam SR, Goodarzi H, Bayani N, Mirzoeva O, Balmain A. Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells. Nat Commun. 2021 Jul 13;12(1):4288.

Education & Training

The Office of Education & Training (OET) is hosting mock interviews for HDFCCC clinical and research staff who are applying for medical school, nurse practitioner or physician assistant programs. Participants will be paired with a UCSF faculty, NP or PA. Each interview will consist of approximately 40 minutes of interview, followed by 20 minutes of feedback. Space is limited. Click here to apply by July 16.
Community Engagement

Join the Office of Community Engagement for a quarterly lecture series highlighting important cancer related information impacting diverse communities. Learn more.
Upcoming Events
A virtual symposium featuring keynote speaker Dr. Mimi Canto, Johns Hopkins University.

Topic: Using Industry Documents to Investigate Commercial Determinants of Cancer

A one-day event that offers virtual plenary sessions and workshops for professional development and resources to enhance faculty life.